Brain Cancer (Treatment)

Vaccine Study Yields Positive Findings

Published in Vaccine Weekly, June 28th, 1999

A vaccine to treat brain cancer has shown promising results in preliminary studies at the University of California Los Angeles (UCLA) Jonsson Cancer Center.

A cover-story article published in the June 1, 1999, issue of the Journal of Neurosurgery describes the findings, expected to serve as a basis for future clinical trials in humans.

Dr. Linda Liau, UCLA's Jonsson Cancer Center, and first author of the article, led the investigation of the vaccine. The vaccine uses powerful immune cells called dendritic cells to stimulate the immune system to attack malignant gliomas, the most fatal type of cancerous brain tumor.

"We observed...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1999-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry